Solesence, Inc. (SLSN) company profile
Close on Nov 18, 2026Market cap $115.86MP/E –Yield –
About Solesence
Perfumes, Cosmetics & Other Toilet Preparations, SIC 2844
Solésence, Inc. develops and manufactures mineral-based skin health, sun care, and cosmetic products, as well as active pharmaceutical ingredients and legacy advanced materials. The company vertically integrates proprietary particle surface treatment and dispersion technologies to produce market-ready, customized white-label, and custom-formulated finished goods, including sunscreens, color cosmetics, and skin care formulations. Additionally, it produces engineered zinc oxide and titanium dioxide ingredients. Solésence serves global prestige beauty and personal care brand partners, alongside corporate customers such as chemical manufacturers.
The company operates development and testing laboratories as well as manufacturing capabilities across two facilities located in the Chicago, Illinois area. It distributes finished consumer products and specialized ingredients to partner brands and customers across domestic and international markets, while maintaining product compliance registrations across several jurisdictions including the United States, Canada, Australia, and Europe. Solésence maintains its principal executive offices in Romeoville, Illinois.
Summary of the business section of Solesence's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Solesence, Inc.
- Founded
- 1989
- Headquarters
- Romeoville, IL
- Address
- 1319 Marquette Drive 60446
- Phone
- (630) 771-6078
- Website
- solesence.com
- Employees
- 115, Dec 31, 2025
- Industry
- Perfumes, Cosmetics & Other Toilet Preparations
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- RSM US LLP, Milwaukee, Wisconsin
Stock & identifiers
- Ticker
- SLSN
- Former tickers
- NANX until May 13, 2025
- Exchange
- Nasdaq
- IPO date
- Nov 26, 1997
- Shares outstanding
- 71M, Aug 19, 2026
- Public float
- $27.25M, Jun 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- SEC CIK
- 883107
- CUSIP
- 630079101
- ISIN
- US6300791018
- FIGI
- BBG000BCLJ87
- Share class FIGI
- BBG001S6M0L5
- EIN
- 36-3687863
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Jess Jankowski | President, CEO, Director | 208,450 |
| Laura C. Riffner | Chief Financial Officer | – |
| Kevin Cureton | Chief Operating Officer | 231,019 |
| R. Janet Whitmore | Director | 2,188,607 |
| Laura M. Beres | Director | – |
| Mark E. Miller | Director | – |
Executive compensation, fiscal 2024
Summary compensation table from the latest proxy statement
| Executive | Salary | Bonus | Option awards | Other | Total | vs. prior year |
|---|---|---|---|---|---|---|
| Jess Jankowski Chief Executive Officer | $357.07K | $141.57K | $39.74K | $26.97K | $565.35K | +51% |
| Kevin Cureton Chief Operating Officer | $309.26K | $111.02K | $39.74K | $21.30K | $481.31K | +49% |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
Employees
Headcount reported in annual reports
“December 31, 2025, we had a total of 115 full-time employees, 15 of whom hold advanced degrees.”
Corporate history
Events identified from SEC filings
See a number that looks wrong?